Gavin Strachan retweeted
Hepatic artery infusion pump chemotherapy for unresectable intrahepatic CCA: Pooled individual patient-level analysis of four clinical trials
@JHepatology
doi.org/10.1016/j.jhep.2026.…
👉PR 53%, DCR 96%
👉mOS 26 mo, 3- and 5- yr OS 28% and 15%
🧐interesting efficacy > multidisciplinary decision-making at specialized centers
@myESMO @ASCO @EASLnews @ILCAnews
Gavin Strachan retweeted
Make Your Voice Heard for Patients 🗣️
Rare cancers like cholangiocarcinoma deserve a place in the FDA’s Rare Disease Framework. Take just one minute to email your elected representatives through our easy-to-use platform and ask them to encourage the FDA to explicitly include rare cancers in this initiative.
Your voice can help raise awareness and support better pathways for research and treatment development.
Get started here. app.oneclickpolitics.com/cam…
Gavin Strachan retweeted
Today is Children’s Grief Awareness Day, a moment to recognize the courage of children and young adults navigating loss.
We are happy to share that, thanks to our sponsor, AstraZeneca, we are able to support families who are grieving through the Grief Care Kit project, which will provide practical resources for families to support grieving children and young adults who have lost a parent or other family member to cholangiocarcinoma.
Let’s remind families, friends, and communities that grief is a journey — and that every child deserves understanding, support, and a safe space to heal.
📦 Request a free Grief Care Kit for a grieving child or young adult today at curecca.link/GriefToolKit.
Gavin Strachan retweeted
This holiday season, we are reminded of how much hope, support, and community can mean to someone facing cholangiocarcinoma. 💚
Just one day after her 60th birthday, Ingrid received a devastating diagnosis: stage IV perihilar cholangiocarcinoma. Like so many others, she had never heard of bile duct cancer before it became part of her life.
Reflecting on her experience, Ingrid shares, “CCF gave me support, education, connection, and hope. Those of us facing this disease need hope the most.”
Through Candles for the Cure, your generosity helps make that hope possible by supporting critical research and providing resources and connection for patients and families.
🕯️ Light a candle for someone you love. Your gift will be doubled dollar for dollar, thanks to a generous $16,000 matching gift from Bob and Gladys Schussel in loving memory of their daughter, Jilly Coyle.
Give today at curecca.link/c4c27,
Gavin Strachan retweeted
🕯️ Finding Support After Loss
The holidays can be especially difficult when you’ve lost someone you love. CCF’s bereaved programs are here to help you connect, share, and find comfort. 💚
During this season, you are not alone; support and understanding are here for you whenever you need them. Together, we can share memories, find comfort, and honor those we’ve lost.
👉 Request a bereaved caregiver mentor: curecca.link/BereavedMentor
💚 Join a bereaved support group: curecca.link/bereaved
Gavin Strachan retweeted
🔬 We are pleased to announce a new data partnership with Tempus AI, leveraging their Lens platform to power real-world research.
CCF has funded a half-time post-doctoral fellow for two years to analyze Tempus’ multimodal BTC dataset alongside the CCF Research Team and external research collaborators. This dataset combines Tempus biomarker test results along with EHR-derived variables, including other biomarker test results, demographics, clinical characteristics, treatments, and outcomes.
With a cohort size of approximately 4,500 individuals, this dataset complements CCF’s existing data resources [Komodo Healthcare Map (insurance claims) and International Cholangiocarcinoma Patient Registry (medical records)].
We will be introducing the Tempus team and their dataset to the ICRN on Dec. 4, 2026, at 10:00 a.m. Eastern / 4:00 p.m. CET.
Do you have a research question that could be addressed by the Tempus dataset or one of our other data resources? ICRN members are invited to submit project proposals for review by the ICRN Data Committee. Approved investigators are granted access to these data sources, along with analytic support (subject to project needs and scoping). Learn more and submit your project proposals at cholangiocarcinoma.org/data-… or contact [email protected].
🔗 Register for the December 4 session: curecca.link/tempusAI.
Gavin Strachan retweeted
At CCF, we know that navigating any aspect of a cholangiocarcinoma journey can be overwhelming, including accessing and understanding biomarker testing.
We're here to help. Our Patient Advocacy Team can support you in advocating to get biomarker testing, better understanding the results, and exploring targeted treatment options and clinical trials.
Head to curecca.link/patientadvocate or the link in our bio to get connected today. 💚
Gavin Strachan retweeted
🧬 Today is Cancer Biomarker Awareness Day! 🧬
Cancer biomarker testing is transforming cancer care, helping ensure patients receive the most effective treatments based on their tumor’s unique molecular profile. However, far too many patients still miss the opportunity to be tested in a timely manner. Biomarker testing should happen before treatment decisions are made.
Clinicians, advocates, patients, and communities all play a role in raising awareness, educating, and advocating for equitable access to testing. Join us in spreading the word and empowering patients to ask for timely testing.
Ask your doctor if biomarker testing could impact your treatment options. #CBAD26
Learn more at biomarkersmatter.org.
Gavin Strachan retweeted
Thank you Patty Maxin for attending the Inaugural Understanding Policies, Innovations and Decisions: Patient and Caregiver Regulatory Symposium.
A patient-focused symposium designed to help patients, caregivers and support teams better understand the policies, processes and practical decisions that shape the transplant journey.
Opportunities like these help empower our community with knowledge, encourage meaningful conversations and ensure patient and caregiver perspectives remain part of the conversation.
Gavin Strachan retweeted
Registration for the 14th Annual Cholangiocarcinoma Foundation Conference is now open. 🎉
Join researchers, clinicians, patients, caregivers, and advocates for a weekend of connection, presentations on the latest advancements in cholangiocarcinoma research, and a community united by hope. The event is in-person only, and everyone is invited to attend the scientific sessions. There will be 1-2 patient- and caregiver-focused breakout sessions on March 23-24.
Register today at: curecca.link/ac2027.
Gavin Strachan retweeted
The Cholangiocarcinoma Foundation honors all veterans for their service and dedication. 🇺🇸
We recognize that military service may have exposed some veterans to risk factors that could contribute to a diagnosis of #cholangiocarcinoma.
CCF has gathered information and resources to support veterans and their families. Learn more about our Veterans Project here: curecca.org/veterans-project
#VeteransDay #CCAhope
Gavin Strachan retweeted
Tomorrow, join @DebbieShawcros1, @JesusMBanales and Gideon Hirschfield as they discuss the practical challenges of translating #CCA risk in #PSC into everyday clinical care.
@tom_marjot @MattiasMandorf1 @PSCPartnersCa @PSCSupportUK
#TalkLiverToMe #LiverX
Cholangiocarcinoma surveillance in PSC remains one of the most challenging areas of clinical practice.
In the latest Talk Liver To Me, experts discuss:
👉 Who should undergo surveillance
👉 The roles and limitations of imaging
👉 What should trigger referral or further investigation
👉 How to manage inconclusive findings
Tune in this Wednesday to catch up on this discussion!
🔗 easl.eu/event/cholangiocarci…
Register for the EASL Liver Cancer Summit: easl.eu/event/easl-liver-can…
Gavin Strachan retweeted
Thank you to Susan Camberis for organizing Smoke Out Cholangiocarcinoma in memory of her beloved husband, James “Jim” Camberis.
Jim was a devoted husband, father, family member, and friend who loved good food and BBQ. In honor of what would have been his 58th birthday, Susan brought family, friends, and community members together this October to celebrate Jim’s life and support the cholangiocarcinoma community.
Thanks to Susan’s heartfelt efforts and the generosity of everyone who participated, $14,475 was raised for the Cholangiocarcinoma Foundation!
Susan, thank you for turning your love for Jim into meaningful support for others affected by this disease. Every dollar helps advance research, strengthen patient and caregiver support, and raise awareness of cholangiocarcinoma.
We are honored to be part of Jim’s legacy and grateful to everyone who helped make this event possible. 💚
Gavin Strachan retweeted
Multikinase Inhibition with Tinengotinib in Advanced SolidTumors: Results from a Multicenter Phase Ib/II Trial
Clinical Cancer Reseach
doi.org/10.1158/1078-0432.CC…
👉Clinicalbenefit was achieved by 43 of 159
🧐Most promising for FGFR2 fusion CCA
@myESMO @ASCO
Gavin Strachan retweeted
Cadonilimab plus gemcitabine and cisplatin as 1L treatment for locally advanced or metastatic biliary tract malignancies: pls II bicureX trial
@NatureComms
doi.org/10.1038/s41467-026-7…
👉ORR 55.7%, DCR 85.2%, DoR 6.1 months,
👉PFS 8.0, OS 15.6mo
🧐support a role for CTL4 in BTC, promising ORR
@myESMO @ASCO @EASLedu @ILCAnews
Gavin Strachan retweeted
Happy Diwali to all who celebrate. 🕯️May this Festival of Lights bring hope, happiness, peace, and brighter days ahead to you and your loved ones. All of us at the CCF wish you a beautiful celebration filled with light and connection.
Gavin Strachan retweeted
"Someone loves this patient more than anything. They are someone’s parent, spouse, or child. They are someone’s everything."
For @TrudyWuMD, cholangiocarcinoma is not just the disease she treats; it is the disease that took her father 11 years ago, long before she became a radiation oncologist.
In an essay published in Practical Radiation Oncology, Dr. Wu reflects on how the grief of losing her father continues to shape the physician she is today. When she sees a family navigating the uncertainty and heartbreak of a cholangiocarcinoma diagnosis, she recognizes something familiar: the desperation of loving someone and wanting more time with them.
Her words remind us that sometimes our deepest experiences of loss can help us show up for others with greater compassion, understanding, and humanity.
Thank you, Dr. Wu, for sharing your story and for the care, compassion, and dedication you bring to patients and families affected by cholangiocarcinoma. Thank you for the work you do to make a difference in our community. 💚
Read the article here: cholangiocarcinoma.org/wp-co….
Gavin Strachan retweeted
Please join us for an Educational Webinar: Insurance and work: Know your rights after diagnosis with Sofia Fernandez, Esq. from Triage Cancer.
Cancer can impact your health insurance and your job at the same time. This webinar will cover the legal rights that protect both, including how to navigate insurance changes, what to know about taking time off or leaving work, and how to ask for workplace accommodations.
Sofia Fernandez is the Staff Attorney at Triage Cancer, her work includes developing educational materials, presenting programs on health-related legal issues, and speaking with individuals about navigating complex systems related to health insurance, employment, and disability insurance.
Register today at curecca.link/nov12.
Gavin Strachan retweeted
📝 Call for Poster Abstracts
The 2027 Annual Conference will include a poster session, providing an opportunity to present ongoing research projects and innovative work in cholangiocarcinoma. Posters allow authors and participants to connect and build upon the shared knowledge and collaboration.
We invite you to submit an abstract for the upcoming Conference.
Abstract Categories:
Advocacy
Basic Science
Translational
Clinical Research
Real World Data
Trials in Progress
Benefits for Poster Presenters include:
Accepted abstracts will be posted on the CCF website and published in The Oncologist journal.
Connect and discuss your work with researchers, clinicians, policymakers, industry representatives, and patients from around the world who are invested in cholangiocarcinoma research.
Visit curecca.link/abstracts27 to submit an abstract by January 6, 2027.
Traveling internationally and need to know if your abstract has been accepted before the January 6 deadline to make travel arrangements? Please reach out to [email protected].
Gavin Strachan retweeted
On this season's finale of Food Network’s Halloween Baking Championship, baker Kyle Caulkins dedicated his final cake to the people who mean the most to him: his family.
At the heart of his tribute was his mom, who was diagnosed with late-stage bile duct cancer when Kyle was in high school. She underwent a liver transplant and gallbladder removal, and Kyle shared the encouraging news that she has been cancer-free for more than two years.
We appreciate Kyle's vulnerability and for helping bring awareness to cholangiocarcinoma and reminding others that behind every diagnosis is a family with a story of its own.
To Kyle and his mom, thank you for sharing your journey and helping raise awareness of bile duct cancer. And to everyone affected by cholangiocarcinoma, please know that you are not alone. The Cholangiocarcinoma Foundation is here to connect patients, caregivers, and families with support, resources, and a community that understands. 💚
Every story shared helps raise awareness of this rare cancer and strengthens the community working toward a future with better treatments and hope.
Learn more at curecca.org.

























